News Release

Notice of Payment for the 36th Round of Stock Options

• Completion of F351 Ib clinical trials and receiving manufacture method patent approval for F351 in China.
• Receipt of Grant Notice and Record of Non-Operation Income at Shanghai Genomics Inc.